Pharma: Other News To Note

 Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, and H. Lundbeck A/S, of Copenhagen, Denmark, said they submitted a new drug application for vortioxetine (Lu AA21004) for the treatment of major depressive disorder in adults.